-+ 0.00%
-+ 0.00%
-+ 0.00%

CULLINAN THERAPEUTICS INC - PHASE 1 CLN-049 MONOTHERAPY DEMONSTRATES PROMISING EFFICACY

Reuters·12/08/2025 15:34:10

Please log in to view news